• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病中的卒中:基于尸检的机制、部位及临床意义研究

Stroke in Dilated Cardiomyopathy: An Autopsy-Based Study of Mechanisms, Topography, and Clinical Implications.

作者信息

Țica Otilia, Sabău Monica, Venter Alina, Beiușanu Corina, Berechet Mihail, Huniadi Anca, Șandor Mircea Ioan, Țica Ovidiu

机构信息

Cardiology Clinic, Emergency County Clinical Hospital of Bihor, 410169 Oradea, Romania.

Department of Psycho-Neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

出版信息

Diagnostics (Basel). 2025 Sep 9;15(18):2287. doi: 10.3390/diagnostics15182287.

DOI:10.3390/diagnostics15182287
PMID:41008659
Abstract

Dilated cardiomyopathy (DCM) is a major cause of heart failure and arrhythmic mortality; yet, its association with cerebrovascular events, particularly in the absence of atrial fibrillation (AF), remains insufficiently explored. Purpose: This study aimed to determine the prevalence, mechanisms, and anatomical distribution of stroke in patients with DCM and to assess the role of AF and structural remodeling in stroke risk. We retrospectively analyzed 471 patients who died with DCM at the Emergency County Clinical Hospital of Bihor between 1 January 2022 and 31 December 2024. Clinical records, neuroimaging, autopsy reports, and histopathological data were reviewed. Stroke subtypes were classified according to TOAST criteria (large artery atherosclerosis, cardioembolic, small vessel disease, other determined, undetermined) and hemorrhagic categories (intracerebral, subarachnoid). Demographic, echocardiographic, and comorbidity data were compared between patients with and without cerebrovascular events. Of 471 patients with DCM, 45 (9.6%) had concomitant stroke: pure ischemic in 32 (71.1%), 7 (15.6%) showed ischemic with hemorrhagic transformation, and primary hemorrhagic in 6 (13.3%). The parietal lobe was most frequently affected. AF was present in 26 patients (57.8%) and was significantly associated with ischemic stroke ( = 0.004), though embolic strokes also occurred in sinus rhythm. Patients with stroke had significantly lower left ventricular ejection fraction (28.0 ± 13.7% vs. 34.0 ± 11.2%, = 0.007) and larger atrial dimensions. Histopathological findings confirmed acute and chronic ischemic injury patterns, including "red neurons," white matter vacuolization, and gliotic scarring. Stroke is a frequent and often underdiagnosed complication in DCM, predominantly ischemic and embolic in nature. Importantly, embolic events were observed even in patients without AF, suggesting that atrial remodeling in DCM may independently predispose to cerebrovascular risk. These results underscore the need for refined preventive strategies, including careful atrial assessment and exploration of whether anticoagulation may benefit selected high-risk DCM patients without AF, a question that requires confirmation in prospective trials. Potential embolic sources in DCM include atrial cardiopathy and left ventricular thrombus in the setting of severe systolic dysfunction; therefore, careful ventricular as well as atrial assessment is warranted in high-risk DCM.

摘要

扩张型心肌病(DCM)是心力衰竭和心律失常导致死亡的主要原因;然而,其与脑血管事件的关联,尤其是在无房颤(AF)的情况下,仍未得到充分研究。目的:本研究旨在确定DCM患者中风的患病率、机制和解剖分布,并评估房颤和结构重塑在中风风险中的作用。我们回顾性分析了2022年1月1日至2024年12月31日期间在比霍尔县急诊临床医院死于DCM的471例患者。对临床记录、神经影像学、尸检报告和组织病理学数据进行了审查。中风亚型根据TOAST标准(大动脉粥样硬化、心源性栓塞、小血管疾病、其他确定型、未确定型)和出血类别(脑内、蛛网膜下腔)进行分类。比较了有和没有脑血管事件的患者的人口统计学、超声心动图和合并症数据。在471例DCM患者中,45例(9.6%)并发中风:32例(71.1%)为单纯缺血性中风,7例(15.6%)表现为缺血性中风伴出血转化,6例(13.3%)为原发性出血性中风。顶叶最常受累。26例患者(57.8%)存在房颤,且房颤与缺血性中风显著相关(P = 0.004),尽管窦性心律时也会发生栓塞性中风。中风患者的左心室射血分数显著更低(28.0±13.7% vs. 34.0±11.2%,P = 0.007),心房尺寸更大。组织病理学结果证实了急性和慢性缺血性损伤模式,包括“红色神经元”、白质空泡化和胶质瘢痕形成。中风是DCM中常见且常被漏诊的并发症,主要为缺血性和栓塞性。重要的是,即使在无房颤的患者中也观察到了栓塞事件,这表明DCM中的心房重塑可能独立增加脑血管风险。这些结果强调了需要完善预防策略,包括仔细评估心房以及探讨抗凝治疗是否可能使选定的无房颤高危DCM患者受益,这一问题需要在前瞻性试验中得到证实。DCM中的潜在栓塞来源包括心房心肌病和严重收缩功能障碍情况下的左心室血栓;因此,对高危DCM患者进行仔细的心室以及心房评估是必要的。

相似文献

1
Stroke in Dilated Cardiomyopathy: An Autopsy-Based Study of Mechanisms, Topography, and Clinical Implications.扩张型心肌病中的卒中:基于尸检的机制、部位及临床意义研究
Diagnostics (Basel). 2025 Sep 9;15(18):2287. doi: 10.3390/diagnostics15182287.
2
Vesicoureteral Reflux膀胱输尿管反流
3
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.在心房颤动患者中,Xa因子抑制剂与维生素K拮抗剂预防脑栓塞或全身性栓塞的比较
Cochrane Database Syst Rev. 2013 Aug 8(8):CD008980. doi: 10.1002/14651858.CD008980.pub2.
4
Mid Forehead Brow Lift额中眉提升术
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Salzmanns Nodular Corneal Degeneration萨尔茨曼结节状角膜变性
7
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy.钠-葡萄糖协同转运蛋白2抑制剂对扩张型心肌病患者内皮功能及超声心动图参数的影响
J Cardiovasc Med (Hagerstown). 2025 Jun 1;26(6):284-296. doi: 10.2459/JCM.0000000000001733. Epub 2025 May 21.
8
Left Ventricular Diastolic Dysfunction with Elevated Filling Pressures Is Associated with Embolic Stroke of Undetermined Source and Atrial Fibrillation.左心室舒张功能障碍伴充盈压升高与不明来源栓塞性卒中和心房颤动有关。
Tomography. 2024 Oct 14;10(10):1694-1705. doi: 10.3390/tomography10100124.
9
Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis.扩张型心肌病患者自身抗体的频率及其相关临床特征和预后:一项系统评价和荟萃分析。
Autoimmun Rev. 2025 Mar 26;24(4):103755. doi: 10.1016/j.autrev.2025.103755. Epub 2025 Jan 22.
10
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.

本文引用的文献

1
Anemia in Heart Failure: Diagnostic Insights and Management Patterns Across Ejection Fraction Phenotypes.心力衰竭中的贫血:不同射血分数表型的诊断见解与管理模式
Diagnostics (Basel). 2025 Aug 19;15(16):2079. doi: 10.3390/diagnostics15162079.
2
Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study.射血分数降低的心力衰竭(HFrEF)患者接受心力衰竭治疗时新型心脏生物标志物sST2、H-FABP、GDF-15和可溶性尿激酶型纤溶酶原激活物受体(suPAR)的动态变化:一项初步研究
J Clin Med. 2025 Aug 11;14(16):5668. doi: 10.3390/jcm14165668.
3
Atrial cardiomyopathy: current clinical perspectives and future insights.
Future Cardiol. 2025 Aug 14:1-9. doi: 10.1080/14796678.2025.2548159.
4
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC.心房心肌病:从健康心房到心房衰竭。欧洲心脏病学会心力衰竭协会临床共识声明。
Eur J Heart Fail. 2025 Aug 5. doi: 10.1002/ejhf.3782.
5
Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized Medicine.心力衰竭中的分子诊断:从生物标志物到个性化医疗。
Diagnostics (Basel). 2025 Jul 17;15(14):1807. doi: 10.3390/diagnostics15141807.
6
Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study.在早期永久性房颤中,房颤持续时间和心脏生物标志物与心血管结局相关:来自RACE II研究的数据。
Int J Cardiol. 2025 Nov 15;439:133669. doi: 10.1016/j.ijcard.2025.133669. Epub 2025 Jul 25.
7
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomized controlled trials.SGLT2抑制剂在心血管疾病全谱中预防心房颤动:一项随机对照试验的荟萃分析
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):441-450. doi: 10.1093/ehjcvp/pvaf040.
8
Galectin-3 and Pentraxin-3 as Potential Biomarkers in Chronic Coronary Syndrome and Atrial Fibrillation: Insights from a 131-Patient Cohort.半乳糖凝集素-3和五聚素-3作为慢性冠状动脉综合征和心房颤动的潜在生物标志物:来自131例患者队列的见解
Int J Mol Sci. 2025 May 20;26(10):4909. doi: 10.3390/ijms26104909.
9
Atrial Cardiomyopathy in Atrial Fibrillation: A Multimodal Diagnostic Framework.心房颤动中的心房心肌病:多模态诊断框架
Diagnostics (Basel). 2025 May 10;15(10):1207. doi: 10.3390/diagnostics15101207.
10
Proteomic-based biomarker discovery reveals panels of diagnostic biomarkers for early identification of heart failure subtypes.基于蛋白质组学的生物标志物发现揭示了用于早期识别心力衰竭亚型的诊断生物标志物组合。
J Transl Med. 2025 May 15;23(1):546. doi: 10.1186/s12967-025-06563-7.